FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894900906> ?p ?o ?g. }

• W2894900906 endingPage "276" @default.
• W2894900906 startingPage "267" @default.
• W2894900906 abstract "Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder which most commonly manifests as pulmonary emphysema. Accordingly, alpha-1 antitrypsin (AAT) augmentation therapy aims to reduce the progression of emphysema, as achieved by life-long weekly slow-drip infusions of plasma-derived affinity-purified human AAT. However, not all AATD patients will receive this therapy, due to either lack of medical coverage or low patient compliance. To circumvent these limitations, attempts are being made to develop lung-directed therapies, including inhaled AAT and locally-delivered AAT gene therapy. Lung transplantation is also an ultimate therapy option. Although less common, AATD patients also present with disease manifestations that extend beyond the lung, including vasculitis, diabetes and panniculitis, and appear to experience longer and more frequent hospitalization times and more frequent pneumonia bouts. In the past decade, new mechanism-based clinical indications for AAT therapy have surfaced, depicting a safe, anti-inflammatory, immunomodulatory and tissue-protective agent. Introduced to non-AATD individuals, AAT appears to provide relief from steroid-refractory graft-versus-host disease, from bacterial infections in cystic fibrosis and from autoimmune diabetes; preclinical studies show benefit also in multiple sclerosis, ulcerative colitis, rheumatoid arthritis, acute myocardial infarction and stroke, as well as ischemia-reperfusion injury and aberrant wound healing processes. While the current augmentation therapy is targeted towards treatment of emphysema, it is suggested that AATD patients may benefit from AAT augmentation therapy geared towards extrapulmonary pathologies as well. Thus, development of mechanism-based, context-specific AAT augmentation therapy protocols is encouraged. In the current review, we will discuss extrapulmonary manifestations of AATD and the potential of AAT augmentation therapy for these conditions." @default.
• W2894900906 created "2018-10-12" @default.
• W2894900906 creator A5015243313 @default.
• W2894900906 creator A5015978922 @default.
• W2894900906 creator A5041058605 @default.
• W2894900906 creator A5055124232 @default.
• W2894900906 creator A5059680649 @default.
• W2894900906 creator A5066620184 @default.
• W2894900906 date "2018-01-01" @default.
• W2894900906 modified "2023-09-26" @default.
• W2894900906 title "Alpha-1 Antitrypsin Substitution for Extrapulmonary Conditions in Alpha-1 Antitrypsin Deficient Patients" @default.
• W2894900906 cites W1540679824 @default.
• W2894900906 cites W1543581240 @default.
• W2894900906 cites W1546437617 @default.
• W2894900906 cites W1908828006 @default.
• W2894900906 cites W1948216765 @default.
• W2894900906 cites W1969730567 @default.
• W2894900906 cites W1970127550 @default.
• W2894900906 cites W1974814369 @default.
• W2894900906 cites W1982508793 @default.
• W2894900906 cites W1983936403 @default.
• W2894900906 cites W1986034298 @default.
• W2894900906 cites W1995228757 @default.
• W2894900906 cites W1996223831 @default.
• W2894900906 cites W1998633680 @default.
• W2894900906 cites W1999650160 @default.
• W2894900906 cites W2000748433 @default.
• W2894900906 cites W2003945200 @default.
• W2894900906 cites W2007798901 @default.
• W2894900906 cites W2017082953 @default.
• W2894900906 cites W2023534857 @default.
• W2894900906 cites W2026910689 @default.
• W2894900906 cites W2029527746 @default.
• W2894900906 cites W2038491254 @default.
• W2894900906 cites W2042905257 @default.
• W2894900906 cites W2047195209 @default.
• W2894900906 cites W2051683789 @default.
• W2894900906 cites W2053998870 @default.
• W2894900906 cites W2054316293 @default.
• W2894900906 cites W2055577311 @default.
• W2894900906 cites W2071104427 @default.
• W2894900906 cites W2074692946 @default.
• W2894900906 cites W2076648110 @default.
• W2894900906 cites W2081169091 @default.
• W2894900906 cites W2081756681 @default.
• W2894900906 cites W2085911000 @default.
• W2894900906 cites W2089687328 @default.
• W2894900906 cites W2090595042 @default.
• W2894900906 cites W2095081588 @default.
• W2894900906 cites W2097366111 @default.
• W2894900906 cites W2098263835 @default.
• W2894900906 cites W2100726280 @default.
• W2894900906 cites W2102793997 @default.
• W2894900906 cites W2107198585 @default.
• W2894900906 cites W2115065911 @default.
• W2894900906 cites W2127903487 @default.
• W2894900906 cites W2130644558 @default.
• W2894900906 cites W2131008616 @default.
• W2894900906 cites W2132440175 @default.
• W2894900906 cites W2135677683 @default.
• W2894900906 cites W2142724633 @default.
• W2894900906 cites W2144684375 @default.
• W2894900906 cites W2148196533 @default.
• W2894900906 cites W2152758152 @default.
• W2894900906 cites W2161807399 @default.
• W2894900906 cites W2168576606 @default.
• W2894900906 cites W2170756834 @default.
• W2894900906 cites W220231536 @default.
• W2894900906 cites W2289844080 @default.
• W2894900906 cites W2307808801 @default.
• W2894900906 cites W2323886210 @default.
• W2894900906 cites W2394719613 @default.
• W2894900906 cites W2398499698 @default.
• W2894900906 cites W2415239352 @default.
• W2894900906 cites W2416046075 @default.
• W2894900906 cites W2462988184 @default.
• W2894900906 cites W2508788470 @default.
• W2894900906 cites W2532287412 @default.
• W2894900906 cites W2550786345 @default.
• W2894900906 cites W2586899188 @default.
• W2894900906 cites W2588550327 @default.
• W2894900906 cites W2590284516 @default.
• W2894900906 cites W2605377626 @default.
• W2894900906 cites W2620394296 @default.
• W2894900906 cites W2733163186 @default.
• W2894900906 cites W2735776813 @default.
• W2894900906 cites W27485535 @default.
• W2894900906 cites W2770847249 @default.
• W2894900906 cites W2785331260 @default.
• W2894900906 cites W2792743785 @default.
• W2894900906 cites W2794325071 @default.
• W2894900906 cites W4211049690 @default.
• W2894900906 doi "https://doi.org/10.15326/jcopdf.5.4.2017.0161" @default.
• W2894900906 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6361480" @default.
• W2894900906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30723784" @default.
• W2894900906 hasPublicationYear "2018" @default.
• W2894900906 type Work @default.
• W2894900906 sameAs 2894900906 @default.

• next